[1]
S. Mor, S. Sindhu, M. Khatri, R. Punia, and K. Jakhar, “Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation, and docking studies of N’-arylidene-2-((7-methylbenzo[4,5]thiazolo[2,3-c] [1,2,4]triazol-3-yl)thio)acetohydrazides”, Eur. J. Chem., vol. 13, no. 4, pp. 426–434, Dec. 2022.